The role of insulin‐like growth factor‐I and its binding proteins in glucose homeostasis and type 2 diabetes
Open Access
- 14 January 2009
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 25 (1), 3-12
- https://doi.org/10.1002/dmrr.919
Abstract
This review addresses the possible role of the insulin‐like growth factor (IGF)‐axis in normal glucose homoeostasis and in the etiopathogenesis of type 2 diabetes. IGF‐I, a peptide hormone, shares amino acid sequence homology with insulin and has insulin‐like activity; most notably, the promotion of glucose uptake by peripheral tissues. Type 2 diabetes as well as pre‐diabetic states, including impaired fasting glucose and impaired glucose tolerance, are associated cross‐sectionally with altered circulating levels of IGF‐I and its binding proteins (IGFBPs). Administration of recombinant human IGF‐I has been reported to improve insulin sensitivity in healthy individuals as well as in patients with insulin resistance and type 2 diabetes. Further, IGF‐I may have beneficial effects on systemic inflammation, a risk factor for type 2 diabetes, and on pancreatic β‐cell mass and function. There is considerable inter‐individual heterogeneity in endogenous levels of IGF‐I and its binding proteins; however, the relationship between these variations and the risk of developing type 2 diabetes has not been extensively investigated. Large prospective studies are required to evaluate this association. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 185 references indexed in Scilit:
- Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adultsGrowth Hormone & IGF Research, 2008
- Insulin, Insulin-like Growth Factor-I, Endogenous Estradiol, and Risk of Colorectal Cancer in Postmenopausal WomenCancer Research, 2008
- Phylogenetic analysis of the insulin-like growth factor binding protein (IGFBP) and IGFBP-related protein gene familiesGeneral and Comparative Endocrinology, 2008
- Differential Activation of Insulin Receptor Substrates 1 and 2 by Insulin-Like Growth Factor-Activated Insulin ReceptorsMolecular and Cellular Biology, 2007
- Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancerEuropean Journal of Cancer, 2005
- C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC)Cancer Causes & Control, 2005
- Growth Inhibition by Insulin-like Growth Factor-binding Protein-3 in T47D Breast Cancer Cells Requires Transforming Growth Factor-β (TGF-β) and the Type II TGF-β ReceptorOnline Journal of Public Health Informatics, 2000
- Receptor Binding, Endocytosis, and Mitogenesis of Insulin‐Like Growth Factors I and II in Fetal Rat Brain NeuronsJournal of Neurochemistry, 1991
- Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy AdultsThe New England Journal of Medicine, 1987
- Impaired Growth Hormone Responses to Growth Hormone–Releasing Factor in ObesityThe New England Journal of Medicine, 1984